| Literature DB >> 33569267 |
Anup Kumar1, Vipul R Patel2, Sridhar Panaiyadiyan3, Kulthe Ramesh Seetharam Bhat2, Marcio Covas Moschovas2, Brusabhanu Nayak3.
Abstract
Robotic-assisted radical prostatectomy (RARP) is the current standard of care with long term cure in organ-confined disease. The introduction of nerve-sparing (NS) to standard RARP has shown positive results in terms of functional outcomes in addition to the oncological outcomes. This article reviews the current perspectives of NS-RARP in terms of applied anatomy of the prostatic fascial planes, the neurovascular bundle (NVB), various NS techniques and postoperative functional outcomes. A non-systematic review was done using PubMed, Embase and Medline databases to retrieve and analyse articles in English, with following keywords "prostate cancer", "robotic radical prostatectomy", "nerve-sparing". The Delphi method was used with an expert panel of robotic surgeons in urology to analyse the potency outcomes of various published comparative and non-comparative studies. The literature has shown that NS-RARP involves various techniques and approaches while there is a lack of randomized studies to suggest the superiority of one over the other. Variables such as preoperative risk assessments, baseline potency, surgical anatomy of individual patients and surgeons' expertise play a major role in the outcomes. A tailored approach for each patient is required for applying the NS approach during RARP.Entities:
Keywords: Nerve-sparing; Prostatectomy; Robot-assisted radical prostatectomy
Year: 2020 PMID: 33569267 PMCID: PMC7859364 DOI: 10.1016/j.ajur.2020.05.012
Source DB: PubMed Journal: Asian J Urol ISSN: 2214-3882
Figure 1Landmark artery on anterolateral aspect of prostate.
Figure 2Left retrograde dissection towards the base of the prostate to completely detach the NVB from the prostatic pedicle. NVB, neurovascular bundle.
Anatomic grading of the proportion of nerve-sparing.
| Grade | Percentage of NS | Description |
|---|---|---|
| Grade 5 | Complete NS (≥95% NS) | After LA is identified and NVB delineated, the NS is performed medial to LA between the prostate and the NVB. The correct plane is confirmed by the pink colour of the prostate. |
| Grade 4 | Near-complete NS (75%) | After LA is identified, NS is completed by a sharp dissection between LA and the prostate capsule across the NVB and the correct planed is confirmed by the strip of fat over the prostate. |
| Grade 3 | Partial NS (50%) | After LA identification, NS is performed by developing a plane lateral to the LA. The correct plane of dissection is denoted by the identification of fat strip over the prostate. |
| Grade 2 | <50% NS | Herein, the NS is performed several millimeters lateral to the LA. |
| Grade 1 | Non-NS (0% NS) | Herein, wide resection of the NVB is performed. The correct plane of dissection is denoted by the presence of levator fascia which is not incised. |
NS, nerve-sparing; LA, landmark artery; NVB, neurovascular bundles.
Figure 3dHAM placed over as right sided nerve wrap on NVB. dHACM, dehydrated human amnion/chorion membrane; NVB, neurovascular bundles.
Figure 4Landmark artery seen as green fluorescent structure over lateral surface of prostate in near infrared fluorescence mode.
Various non comparative studies reporting potency outcomes in patients undergoing robot-assisted radical prostatectomy.
| Year of the study | Author | Number of patients | Mean age (year) | NS technique | Definition of potency | Follow-up (month) | Potency rate (unilateral NS) | Potency rate (bilateral NS) | Potency rate (overall) |
|---|---|---|---|---|---|---|---|---|---|
| 2007 | Menon et al. [ | 721 | 60.2 | Antegrade | Adequate erection for intercourse±PDE 5 inhibitors | 12 | – | 79.2% | 79.2% |
| 2009 | Potdevin et al. [ | 147 | 58.5 | Retrograde (Interfascial–77 | Adequate erection for intercourse±PDE 5 inhibitors | 9 | – | – | 3 months–16.67% |
| 2009 | Shikanov et al. [ | 813 | 60 | Antegrade (Extrafascial–110 | Adequate erection for intercourse±PDE 5 inhibitors | 8 | – | – | 3 months–22% |
| 2010 | Patel et al. [ | 404 | 58 | Retrograde | Adequate erection for intercourse in >50% of attempts±PDE 5 inhibitors | 18 | – | 53.5%–6 weeks | – |
| 2011 | Patel et al. [ | 332 | 58.5 | Retrograde | Adequate erection for intercourse in >50% of attempts±PDE 5 inhibitors | 12 (minimum) | – | 53.9%–6 weeks | – |
| 2011 | Kowalczyk et al. [ | 342–NS-0C | 59.6 | Antegrade | Adequate erection for intercourse±PDE 5 inhibitors | 12 | – | 5 months–45% | – |
| 2012 | Alemozaffar et al. [ | 400 | 59.8 | Retrograde | Adequate erection for intercourse±PDE 5 inhibitors | 12 | – | – | 5 months–33.3% |
| 2013 | Ko et al. [ | 344 | 57.9 | Antegrade NS–172 | Adequate erection for intercourse in >50% of attempts±PDE 5 inhibitors | 12 (minimum) | – | 3 months–65% | – |
| 2013 | Ficarra et al. [ | 183 | 62.3 | Antegrade | Adequate erection for intercourse±PDE 5 inhibitors | 81.3 | – | – | 10%–3 months |
PDE, phosphodiesterase; NS, nerve-sparing; NS-0C, nerve-sparing without assistant's countertraction; NS-C, nerve-sparing with assistant's countertraction.
–, data not given in the study.
Studies comparing outcomes between RARP vs. RRP.
| Year | Author | Study design | Number of patients ( | Mean age (year) | Follow-up (month) | Inclusion criteria | Definition of potency | NS technique | Potency rate (unilateral NS) | Potency rate (bilateral NS) | Potency rate (overall) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2009 | Krambeck et al. [ | RRP | 588 | 61 | 12 | All patients | Adequate erection for intercourse in last 4 weeks ± PDE 5 inhibitors | Antegrade | 62.8% | ||
| 2009 | Rocco et al. [ | RRP | 105 | 63 | 12 | All patients | Adequate erection for intercourse in last 4 weeks ± PDE 5 inhibitors | Retrograde | – | – | 41% |
| 2009 | Ficarra et al. [ | RRP | 588 | 61 | 12 | Consecutive patients with bilateral NS | 11 EF >17 | Antegrade | – | 49% |
RARP, robot-assisted radical prostatectomy; RRP, open retropubic radical prostatectomy; PDE, phosphodiesterase; NS, nerve-sparing.
–, data not given in the study.
Studies comparing outcomes between robot-assisted RARP vs. LRP.
| Year | Author | Study design | Number of patients ( | Mean age (year) | Follow-up (month) | Inclusion criteria | Definition of potency | Nerve-sparing technique | Potency rate (unilateral NS) | Potency rate (bilateral NS) | Potency rate (overall) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2012 | Willis et al. [ | RARP | 174 | 58.1 | 12 | Consecutive patients with localized prostate cancer | Adequate erection for intercourse in last 4 weeks±PDE 5 inhibitors | Antegrade | – | – | 3 months–59.8% |
| 2013 | Berge et al. [ | LRP | 210 | 61.7 | 36 | Consecutive patients with localized prostate cancer | Adequate erection for intercourse±PDE 5 inhibitors | Antegrade | 40.2% | 57.3% | – |
| 2013 | Porpiglia et al. [ | RARP | 60 | 63.9 | 12 | Consecutive patients with localized prostate cancer | IIEF-5 score >17 | Antegrade | – | – | 80% |
| 2013 | Asimakopoulos et al. [ | LRP | 91 | 63 | 18 | Age ≤70 years, clinically localized prostate cancer, preoperativepotent, with bilateral NS | Adequate erection for intercourse in last 4 weeks ± PDE 5 inhibitors | Antegrade | – | – | 66.2% |
RARP, robot-assisted radical prostatectomy; LRP, laparoscopic radical prostatectomy; PDE, phosphodiesterase; NS, nerve-sparing.
–, data not given in the study.